DYNAMICS OF HEMOSTASIS AND NEUTROPHIL FUNCTIONAL ACTIVITY CHANGES IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE MYOCARDIAL INFARCTION

DYNAMICS OF HEMOSTASIS AND NEUTROPHIL FUNCTIONAL ACTIVITY CHANGES IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE MYOCARDIAL INFARCTION

Aim. To study in dynamics the specifics of hemostasis and functioning of neutrophilic granulocytes in patients with acute myocardial infarction (MI) sensitive and resistant to acetylsalicylic acid (ASC).Material and methods. Totally, 53 patients included during first 24 hours from MI onset. Controls...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, N. Yu. Shimokhina, M. M. Petrova, I. I. Gvozdev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-08-01
Series:	Российский кардиологический журнал
Subjects:	acute myocardial infarction acetylsalicylic acid platelets aggregation neutrophils chemiluminiscent activity
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/509
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome
by: I. Yu. Grinshtein, et al.
Published: (2016-11-01)

Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease
by: M. D. Goncharov, et al.
Published: (2021-03-01)

COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR)
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-02-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

Dynamic regulation of neutrophil immunometabolism by platelet-derived metabolites
by: Manuel Alejandro Mosso-Pani, et al.
Published: (2025-03-01)

CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY
by: Yu. I. Grinshtein, et al.
Published: (2016-06-01)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period
by: T. P. Pronko, et al.
Published: (2025-01-01)

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: N. A. Belolipetskiy, et al.
Published: (2016-01-01)

Postgenomic aspects of resistance to acetylsalicylic acid in patients with coronary artery disease
by: Yu. I. Grinshtein, et al.
Published: (2024-11-01)

Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01)

FUNCTIONAL ACTIVITY OF NEUTROPHILS AND HEMOSTASIS PATTERN IN PATIENTS WITH ACUTE DESTRUCTIVE PANCREATITIS
by: A. A. Savchenko, et al.
Published: (2018-06-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01)

Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery
by: A. A. Kosinova, et al.
Published: (2019-07-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
by: M. Y. Zhuk, et al.
Published: (2003-10-01)

Zyllt and acetylsalicylic acid in coronary atherosclerosis patients after coronary artery bypass graft intervention. Main results of the ZEUS Study: medication effectiveness, acetylsalicylic acid resistance mechanisms, short and long-term clinical outcomes
by: Yu. I. Grinstein, et al.
Published: (2009-08-01)

ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
by: S. A. Boldueva, et al.
Published: (2015-12-01)

Association of T715P (RS6136), M62I (RS2228315), S290N (RS6131), V640L (RS6133) polymorphisms in the P-selectin gene and its ligand with acetylsalicylic acid resistance in patients with coronary artery disease after coronary artery bypass grafting
by: A. A. Kosinova, et al.
Published: (2019-11-01)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

ASSAY OF ACETYLSALICYLIC ACID IN DRUG PRODUCTS BY DIFFERENTIAL SCANNING CALORIMETRY
by: A. M. Stoinova, et al.
Published: (2019-01-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

Aspirin resistance in patients with acute coronary syndrome. Part 2
by: N. S. Frolova, et al.
Published: (2011-04-01)

Aspirin resistance in patients with acute coronary syndrome. Part 1
by: N. S. Frolova, et al.
Published: (2010-12-01)

Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-03-01)

Association Between Neutrophil Percentage to-Albumin Ratio, Neutrophil to-Lymphocyte Ratio, Platelet-to Lymphocyte Ratio and in-Hospital Mortality in Elder Patients with Bloodstream Infections
by: Yu Z, et al.
Published: (2025-08-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

CYTOKINE REGULATION OF RESPIRATORY BURST IN BLOOD NEUTROPHILS FOR PREDICTION OF ABDOMINAL SEPSIS IN PATIENTS WITH EXTENDED PURULENT PERITONITIS
by: A. A. Savchenko, et al.
Published: (2016-08-01)

Immunophenotype and metabolism are linked in peripheral blood neutrophils from patients with kidney cancer
by: A. A. Savchenko, et al.
Published: (2020-12-01)